Nuvation Bio Inc. (NUVB) FY2026 Q2 Statement of Cash Flows
2026-04-01 to 2026-06-30
Statement of Cash Flows
2026-04-01 to 2026-06-30
Swipe to see the full flow
Chart details
Nuvation Bio Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026
Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Mar 31, 2026
- 125,391,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- negative 42,969,000 US dollars. Net cash used.
- Net loss
- negative 62,840,000 US dollars
- Stock-based compensation
- 10,460,000 US dollars
- Depreciation and amortization
- 536,000 US dollars
- Non-cash lease expense
- negative 54,000 US dollars
- Non-cash interest on revenue interest financing agreement
- 5,097,000 US dollars
- Amortization of debt issuance costs
- 350,000 US dollars
- Change in fair value of warrant liability
- 0 US dollars
- Amortization of premium and discounts on marketable securities
- negative 711,000 US dollars
- Net loss on disposal of fixed assets
- negative 1,000 US dollars
- Loss on debt extinguishment
- 9,472,000 US dollars
- Realized loss (gain) on marketable securities
- negative 9,000 US dollars
- Unrealized foreign currency transaction (loss) gain
- negative 208,000 US dollars
- Accounts receivable
- negative 5,103,000 US dollars
- Prepaid expenses and other current assets
- 2,111,000 US dollars
- Intangible assets
- 0 US dollars
- Inventory
- negative 4,057,000 US dollars
- Interest receivable on marketable securities
- negative 627,000 US dollars
- Other non-current assets
- 0 US dollars
- Accounts payable
- negative 9,846,000 US dollars
- Contract liabilities
- negative 1,311,000 US dollars
- Accrued expenses
- 13,772,000 US dollars
- Investing activities
- 5,991,000 US dollars. Net cash provided.
- Purchases of marketable securities
- negative 67,694,000 US dollars
- Proceeds from sale of marketable securities
- 73,939,000 US dollars
- Purchases of property and equipment
- negative 254,000 US dollars
- Financing activities
- 170,529,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the financing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Payments on revenue interest financing agreement), so Payments on debt issuance costs, Payments on capped call transactions, Proceeds from issuance of Common Stock under ESPP, Proceeds from revenue interest financing agreement, Payments on revenue interest financing agreement, Proceeds from convertible debt and Proceeds from borrowings, net of debt issuance costs and debt discounts cannot be separated for this quarter. It may combine inflows and outflows.
- Payments on borrowings and amendment fee under Financing Agreement
- negative 58,687,000 US dollars
- Proceeds from exercises of options
- 3,501,000 US dollars
- Remaining financing cash flows, net (calculated)
- 225,715,000 US dollars
- Operating adjustment reconciliation
- 84,767,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing displayed reconciliation
- 229,216,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
- investing gross reconciliation
- 73,939,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- negative 338,000 US dollars
- Ending cash on Jun 30, 2026
- 258,604,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 301,911,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 133,213,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$62.84M + net operating adjustments $19.87M = operating cash −$42.97M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!